brentuximab vedotin

brentuximab vedotin
Trade Name Adcetris
Orphan Indication T-cell lymphoma
USA Market Approval USA
USA Designation Date 2013-09-13 00:00:00
Sponsor Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021